The 14,897 Shares of Stock are sold by Cantel Medical Corp. (CMN) Chairman Charles M. Diker

The 14,897 Shares of Stock are sold by Cantel Medical Corp. (CMN) Chairman Charles M. Diker

Cantel Medical Corp. (NYSE:CMN) Chairman Charles M. Diker sold 14,897 shares of the company’s stock in a transaction dated Monday, October 10th. The shares were sold at an average price of $78.76, for a total transaction of $1,173,287.72. Following the completion of the transaction, the chairman now owns 3,190,111 shares in the company, valued at approximately $251,253,142.36. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Cantel Medical Corp. (NYSE:CMN) opened at 76.88 on Thursday. The firm’s 50 day moving average is $77.65 and its 200-day moving average is $71.18. The firm has a market cap of $3.18 billion, a price-to-earnings ratio of 53.46 and a beta of 1.59. Cantel Medical Corp. has a 12 month low of $53.64 and a 12 month high of $81.63.

Cantel Medical Corp. (NYSE:CMN) last posted its quarterly earnings results on Thursday, September 29th. The company reported $0.48 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.37 by $0.11. Cantel Medical Corp. had a net margin of 9.02% and a return on equity of 16.70%. The company had revenue of $179 million for the quarter. During the same period last year, the firm earned $0.39 EPS. The business’s revenue for the quarter was up 18.3% on a year-over-year basis. On average, equities analysts forecast that Cantel Medical Corp. will post $1.98 EPS for the current year.

A number of research analysts recently commented on CMN shares. Benchmark Co. set a $83.00 price target on shares of Cantel Medical Corp. and gave the company a “buy” rating in a research note on Saturday, October 1st. Needham & Company LLC assumed coverage on shares of Cantel Medical Corp. in a research note on Wednesday, August 24th. They issued a “hold” rating on the stock.

Hedge funds have recently bought and sold shares of the stock. LS Investment Advisors LLC boosted its position in shares of Cantel Medical Corp. by 7.5% in the second quarter. LS Investment Advisors LLC now owns 1,510 shares of the company’s stock valued at $104,000 after buying an additional 106 shares in the last quarter. ProShare Advisors LLC boosted its position in shares of Cantel Medical Corp. by 3.2% in the second quarter. ProShare Advisors LLC now owns 5,186 shares of the company’s stock valued at $356,000 after buying an additional 160 shares in the last quarter. UBS Asset Management Americas Inc. boosted its position in shares of Cantel Medical Corp. by 0.7% in the second quarter. UBS Asset Management Americas Inc. now owns 23,099 shares of the company’s stock valued at $1,588,000 after buying an additional 163 shares in the last quarter. PineBridge Investments L.P. boosted its position in shares of Cantel Medical Corp. by 3.8% in the second quarter. PineBridge Investments L.P. now owns 4,548 shares of the company’s stock valued at $312,000 after buying an additional 165 shares in the last quarter. Finally, Arizona State Retirement System boosted its position in shares of Cantel Medical Corp. by 1.1% in the second quarter. Arizona State Retirement System now owns 18,647 shares of the company’s stock valued at $1,282,000 after buying an additional 200 shares in the last quarter. 81.60% of the stock is currently owned by institutional investors.

About Cantel Medical Corp.

Related posts

Leave a Comment